Birgit Eiermann
YOU?
Author Swipe
View article: An Adverse Drug Reaction Database for Clinical Use – Potential of and Difficulties with the Summary of Product Characteristics
An Adverse Drug Reaction Database for Clinical Use – Potential of and Difficulties with the Summary of Product Characteristics Open
Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients’ drug list can support healthcare staff to link patient symptoms…
View article: ADR databases for on‐site clinical use: Potentials of summary of products characteristics
ADR databases for on‐site clinical use: Potentials of summary of products characteristics Open
Adverse drug reactions (ADRs) for all drugs in Europe are described in the legally approved Summary of Product Characteristics (SmPC). An overview of all ADRs of the patients’ drug list can support healthcare staff to link patient symptoms…
View article: Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy Open
Model-informed precision dosing (MIPD) has become synonymous with modern approaches for individualizing drug therapy, in which the characteristics of each patient are considered as opposed to applying a one-size-fits-all alternative. This …
View article: Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet Open
Evidence-based, publicly funded, well-structured and curated knowledge bases are of global importance. They ought to be considered as a public responsibility requiring transparency and handling of conflicts of interest. Information has to …
View article: Prevalence of potential drug-drug interactions in Swedish pediatric outpatients
Prevalence of potential drug-drug interactions in Swedish pediatric outpatients Open
We identified a limited number of drugs that were represented in the majority of potential interactions. Interactions that can lead to a reduced treatment effect constituted approximately half of D-interactions, and a third of C-interactio…
View article: High Prevalence of Drug–Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units
High Prevalence of Drug–Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units Open
Drug–drug interactions are increasingly common, as patients are getting older and the number of drugs per patient is increasing. In this study, we investigated to which extent potential drug–drug interactions originated from single or mult…